Significant Clinical Advantages of Librium

https://aihp.org/wp-content/uploads/2022/01/msdac-034.1a-librium.jpg
https://aihp.org/wp-content/uploads/2022/01/msdac-034.2a-librium.jpg

Title

Significant Clinical Advantages of Librium

Description

Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on January 5, 1970. The ad reports that Librium effectively relieves anxiety across a range of medical conditions with an anxiety component, by acting on key areas of the brain's limbic system.

Creator

Publisher

Date

Rights

The advertisements in the AIHP Mickey Smith Drug Advertising Collection were published after 1923 and are not in the public domain. Under Fair Use, users may view or reproduce (print or download) materials from the collection for research, teaching, private study, or general interest. Users must provide proper attribution to the AIHP Mickey Smith Drug Advertising Collection in all copies. For any other uses, including reprinting or reproduction, users must contact the current rights holder for permission. For more information about the collection, please contact the American Institute of the History of Pharmacy: aihp@aihp.org.
http://rightsstatements.org/vocab/InC/1.0/

Format

Language

eng

Identifier

msdac-034-librium

Extent

2 pages

Temporal Coverage

Original Format

Citation

Roche, “Significant Clinical Advantages of Librium,” American Institute of the History of Pharmacy Digital Collection, accessed January 27, 2023, https://aihp.omeka.net/items/show/663.